VA Disability Rating for Malignant neoplasms of the genitourinary system (DC 7528)

Body system: Genitourinary SystemRegulation: 38 CFR § 4.115bDBQ: GU Urinary Tract Conditions; GU Kidney; GU Male Reproductive Organ

DC 7528 covers all malignant neoplasms (cancers) of the genitourinary system: kidney, renal pelvis, ureter, bladder, urethra, prostate, testicular, penile, and other GU primary cancers, including metastatic disease. The VA assigns 100% during ACTIVE cancer and for SIX MONTHS following the cessation of all therapeutic procedures (surgery, radiation, chemotherapy, immunotherapy, hormonal therapy). At 6 months a mandatory VA examination is conducted to determine whether the cancer is still present. If no local recurrence or metastasis is found, the rating transitions to a residual rating based on the predominant residual symptom: voiding dysfunction (0-60%) for urinary symptoms or renal dysfunction (0-100%) for kidney function damage. Any reduction from 100% triggers 38 CFR § 3.105(e) due-process protection.

Rating levels

  • 100%: You qualify for 100% during ACTIVE genitourinary cancer (kidney, bladder, prostate, testicular, urethral, ureteral, or related GU malignancy). The 100% rating covers the active treatment period AND continues for SIX MONTHS after cessation of all therapeutic procedures (surgery, radiation, chemotherapy, immunotherapy, hormonal therapy). At the 6-month mark a mandatory VA examination is scheduled (see Note 1). The 100% rating is not affected by the prognosis or stage — it applies during active disease and the immediate post-treatment window.
  • Note: At the 6-month mark following cessation of all cancer treatment, the VA must schedule and conduct a mandatory examination. The outcome of that exam (and any subsequent exam) determines whether the 100% rating continues or transitions to a residual rating. ANY reduction from 100% is governed by 38 CFR § 3.105(e), which requires the VA to give written notice of the proposed reduction, provide 60 days for the veteran to submit evidence and request a personal hearing, and provide an additional 60 days notice before reducing pay. These due-process protections cannot be skipped — a reduction without § 3.105(e) compliance is procedurally invalid.
  • Note: If the 6-month mandatory exam (or any later exam) shows NO local recurrence and NO metastasis, the rating transitions from 100% to a residual rating. The residual rating is taken from whichever ladder best matches the predominant residual symptom: voiding dysfunction (urine leakage / urinary frequency / obstructed voiding sub-formulas, 0-60%) if urinary symptoms predominate, OR renal dysfunction (0/30/60/80/100%) if kidney function damage predominates. The reduction itself triggers § 3.105(e) due-process protection; the 100% rating stays in place until that process is complete. If recurrence or metastasis is found, the 100% rating continues without transition.

Symptoms Recorded in Granted Genitourinary Cancer DecisionsCollapse

We analyzed 3,701 granted Board decisions involving genitourinary cancer for symptoms named in sentences about the condition (rating-criteria recitations excluded). Descriptive of the published record, what the Board wrote down, not a checklist of what to report.

VA's rule for DC 7528, word for word

If there has been no local reoccurrence or metastasis, rate on residuals as voiding dysfunction or renal dysfunction, whichever is predominant

VA's words that name a symptom charted below. Every level is in Rating Levels above, under the "Official VA criteria" tab.

Bar length shows decisions. Percentages remain context.

Erectile dysfunction
491 decisions13.3% of granted
Voiding dysfunction"voiding" in VA's sentence above
415 decisions11.2% of granted
Urine leakage needing pads
271 decisions7.3% of granted
Urinary frequency
187 decisions5.1% of granted
Nighttime urination
129 decisions3.5% of granted
Weak urine stream
14 decisions0.4% of granted

A small blue tag means VA's sentence names the same symptom, in the same word or its medical word. The bars count any mention of the symptom, at any severity, even to say it was absent. VA's sentence has its own conditions. A tag does not show that any rating level was met, and a symptom with no tag can still matter.

VA's words are today's rule (38 CFR 4.115b, last amended November 14, 2021). The bars cover decisions from 1992 to 2026, decided under the wording of their time, which may have named different symptoms.

These bars count whole decisions whose overall result was granted. The At the Board box on this page counts each appealed issue, so its granted number is larger.

Detected by phrase-reading the decision text with condition-specific vocabularies. Source: Board of Veterans' Appeals decisions, RateMyVSO analysis.

Disclaimer: This tool is for informational purposes only and is not legal or medical advice. Always consult with your VSO representative or a VA-accredited attorney for guidance on your specific claim.